Search This Blog

Thursday, March 28, 2019

Fate Therapeutics initiated with an Outperform at SVB Leerink

SVB Leerink initiated Fate Therapeutics with an Outperform and $20 price target.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)